What TV doesn't, print can't; we deliver.
What TV doesn't, print can't; we deliver.
India’s first intranasal anti-Covid vaccine, manufactured by Hyderabad-based Bharat Biocon, has been approved by the Drugs Controller General of India (DGCI). The vaccine can be used for primary immunization in emergency situations in people above 18 years of age, as per the Ministry of Health. “This step will further strengthen our collective fight against the pandemic. India […]
Bharat Biotech International Limited (BBIL) on Monday said that it has completed the phase III trials and booster doses for the Covaxin Intranasal Covid-19 vaccine.
